Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|40|6134-6141

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.40, 2016-12, pp. : 6134-6141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-01 ,pp. : 1096-1119

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Gut Microbiota in Drug Response

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1519-1523

Bentham Science Publishers

Access to resources Recommend Favorite

Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis: Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 9, 2018-01 ,pp. : 971-973

Bentham Science Publishers

Access to resources Recommend Favorite

Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala

By  

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 148-167

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Gut Microbiota in Age-Related Chronic Inflammation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 4, 2012-12 ,pp. : 361-367

Bentham Science Publishers

Access to resources Recommend Favorite